This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on ISI (1)  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Topic Collections  • Diabetes Mellitus  • Hypertension  • Alert me on articles by topic

Iddo Z. Ben-Dov, MD; Drori Ben-Ishay, MD; Judith Mekler, MSc; Liora Ben-Arie; Michael Bursztyn, MD

Arch Intern Med. 2007;167(19):2139-2142.

	Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

Hypertensive-type target organ damage is increased in patients with diabetes mellitus compared with blood pressure–matched individuals with euglycemia.^1-8 Hyperglycemia and accompanying metabolic abnormalities partly explain this gap.⁹ Another possible explanation is a lower sensitivity of clinic blood pressure measurements in diabetic patients.^10-11 Failure of clinic measurements to detect out-of-office elevated blood pressure results in the recently characterized entity of "masked hypertension," also known as isolated ambulatory hypertension and reverse white-coat hypertension, in which "true" blood pressure is underestimated and thus undertreated (among subjects with treated hypertension, these terms refer to masked uncontrolled hypertension¹²). The prognostic consequences of masked hypertension are similar to those of sustained hypertension.^13-14 Several studies have documented a higher level of target organ damage among subjects with treated hypertension and "masked" blood pressure elevation, namely, misleadingly controlled clinic blood pressure.^15-18

. . . [Full Text of this Article]

Methods


Results

Comment

AUTHOR INFORMATION